ADEL K EL-NAGGAR to Drug Antagonism
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Drug Antagonism.
Connection Strength
0.025
-
Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48.
Score: 0.025